SI1962895T1 - THERAPEUTIC USE OF A Dll4 ANTAGONIST AND A VEGF INHIBITOR FOR INHIBITING TUMOR GROWTH - Google Patents

THERAPEUTIC USE OF A Dll4 ANTAGONIST AND A VEGF INHIBITOR FOR INHIBITING TUMOR GROWTH

Info

Publication number
SI1962895T1
SI1962895T1 SI200631536T SI200631536T SI1962895T1 SI 1962895 T1 SI1962895 T1 SI 1962895T1 SI 200631536 T SI200631536 T SI 200631536T SI 200631536 T SI200631536 T SI 200631536T SI 1962895 T1 SI1962895 T1 SI 1962895T1
Authority
SI
Slovenia
Prior art keywords
tumor growth
therapeutic use
inhibiting tumor
vegf inhibitor
dll4 antagonist
Prior art date
Application number
SI200631536T
Other languages
Slovenian (sl)
Inventor
Irene Noguera
Gavin Thurston
Nicholas Gale
Eric Smith
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Priority claimed from EP06848586.1A external-priority patent/EP1962895B2/en
Publication of SI1962895T1 publication Critical patent/SI1962895T1/en

Links

SI200631536T 2005-12-16 2006-12-15 THERAPEUTIC USE OF A Dll4 ANTAGONIST AND A VEGF INHIBITOR FOR INHIBITING TUMOR GROWTH SI1962895T1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US75117305P 2005-12-16 2005-12-16
US77127606P 2006-02-08 2006-02-08
US78845606P 2006-03-31 2006-03-31
US83054306P 2006-07-12 2006-07-12
EP06848586.1A EP1962895B2 (en) 2005-12-16 2006-12-15 THERAPEUTIC USE OF A Dll4 ANTAGONIST AND A VEGF INHIBITOR FOR INHIBITING TUMOR GROWTH
PCT/US2006/047848 WO2007070671A2 (en) 2005-12-16 2006-12-15 Therapeutic methods for inhibiting tumor growth with dll4 antagonists

Publications (1)

Publication Number Publication Date
SI1962895T1 true SI1962895T1 (en) 2013-04-30

Family

ID=40206357

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631536T SI1962895T1 (en) 2005-12-16 2006-12-15 THERAPEUTIC USE OF A Dll4 ANTAGONIST AND A VEGF INHIBITOR FOR INHIBITING TUMOR GROWTH

Country Status (2)

Country Link
CN (1) CN101330925A (en)
SI (1) SI1962895T1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011223919B2 (en) * 2010-03-02 2015-03-19 Abbvie Inc. Therapeutic DLL4 binding proteins
PT3687287T (en) * 2017-09-29 2023-11-03 Regeneron Pharma Non-human animals expressing humanized c1q complex
CN111234003B (en) * 2020-02-07 2022-02-01 中国人民解放军第四军医大学 Short peptide for cancer targeted therapy, ultrasound response nano drug-loaded microbubble based on short peptide and application of short peptide

Also Published As

Publication number Publication date
CN101330925A (en) 2008-12-24

Similar Documents

Publication Publication Date Title
PL1962895T3 (en) THERAPEUTIC USE OF A Dll4 ANTAGONIST AND A VEGF INHIBITOR FOR INHIBITING TUMOR GROWTH
EP1753428A4 (en) Kinase inhibitors as therapeutic agents
HK1139036A1 (en) Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
IL179514A0 (en) Method of administering and using vegf inhibitors for the treatment of malignant pleural effusion
ZA200704796B (en) Selecting patients for therapy with a HER inhibitor
EP2026843A4 (en) Therapeutic uses of inhibitors of rtp801l
EP2063897A4 (en) Kinase inhibitors useful for the treatment of proliferative diseases
EP2063896A4 (en) Kinase inhibitors useful for the treatment of proliferative diseases
IL201650A0 (en) Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
EP2143443A4 (en) Combined use of dipeptidyl peptidase iv inhibitor compound and sweetener
GB0625659D0 (en) Therapeutic compounds and their use
HK1112895A1 (en) 5-heteroaryl thiazoles and their use as pi3k inhibitors
EP1812432A4 (en) Combination of a src kinase inhibitor and a bcr-abl inhibitor for the treatment of proliferative diseases
EP1827391A4 (en) Dosage forms and methods of use thereof
ZA200610772B (en) Quinazolinone derivatives as PARP inhibitors
PL1999136T3 (en) Peptidomimetic inhibitors of psma,compounds comprising them, and methods of use
EP2046122A4 (en) Heme oxygenase inhibitors and methods of therapeutic use
HK1133597A1 (en) Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor
EP1789027A4 (en) Therapeutic use of anti-tf-antigen antibody
ZA200710218B (en) Mitotic kinesin inhibitors and methods of use thereof
HK1170908A1 (en) Novel compounds and therapeutic use thereof for protein kinase inhibition
IL206891A0 (en) Therapeutic inhibitors of pai-1 function and methods of their use
EP1951286A4 (en) Combined use of dpp iv inhibitors and gastrin compounds
GB0422439D0 (en) Inhibitors of infection
SI1962895T1 (en) THERAPEUTIC USE OF A Dll4 ANTAGONIST AND A VEGF INHIBITOR FOR INHIBITING TUMOR GROWTH